Integration of Virtual Reality Mindfulness Application Within a Mobile-Based Recovery Platform to Support Rehab and Post-Rehab Engagement
Integration of Virtual Reality Mindfulness Application Within a Mobile-Based Recovery Platform to Support Rehab and Post-Rehab Engagement
批准号:
9898123
负责人:
Beau Mann
金额:
$22.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-30 至 2021-01-31
关键词:
AftercareAlcohol dependenceAlcohol or Other Drugs useAlcoholsAndroidCaringCellular PhoneClinicClinicalCommunitiesCoupledDevelopmentDrug AddictionEnhancement TechnologyFeedbackFocus GroupsHealthHealth Services AccessibilityHealthcare SystemsHome environmentImmersion Investigative TechniqueIndividualInformal Social ControlInpatientsInterventionMedical DeviceMental HealthMethodsMissionOpioidOutcomeParticipantPatientsPersonal SatisfactionPersonsPhasePopulationPreparationProductionProtocols documentationPsyche structureRandomizedRecoveryRelapseResearchResourcesScientistServicesStructureSubstance Use DisorderTechnologyTestingTherapeuticTherapeutic EffectTimeTrainingTraining SupportTreatment EfficacyUniversitiesVisualWell in selfaddictionbasecostcost effectivedesignevidence baseexperienceimprovedinnovationinpatient servicemachine learning algorithmmembermindfulnessmindfulness interventionmobile applicationnew technologypeerpeer coachingpeer supportprototyperelapse predictionrelapse risksobrietysocialsound frequencysuccesstelehealththerapy designtreatment as usualtreatment programvirtual reality
中文摘要
摘要
英文摘要
ABSTRACT
Post-treatment substance use disorder (SUD) relapse rates are high (40-60% at one year), with relapse
occurring early (median time to relapse 1-3 months), indicating that the transition period from inpatient care to
the home environment is particularly challenging for patients seeking sobriety. Telehealth and VR technologies
have the ability to greatly increase the accessibility of highly engaging recovery support. Combining these two
approaches provides a unique opportunity to create a highly engaging, cost-effective take home recovery support
solution targeting the critical transition from inpatient care.
Sober Grid proposes to leverage its existing highly accessible social and peer coaching mobile recovery app, to
develop a convenient and cost-effective integrated take-home combined VR and professional peer coaching
recovery support intervention (RecoVRi) that begins in the inpatient clinic. RecoVRi is designed to increase
engagement with recovery therapy during the critical transition from inpatient to home, thereby reducing the risk
of relapse and associated health and monetary costs. Sober Grid is collaborating with TRIPP, Inc. to utilize
TRIPP’s immersive wellness platform. The design of the TRIPP experience leverages a large body of existing
research on the use of VR technology in the mental wellness arena and utilizes proven mindfulness structures,
targeted sound frequencies, visuals and interactions that have a multiplicative effect when administered through
immersion. The Sober Grid Network will create a support wrapper to the VR experience that facilitates access to
crisis management experts and community for the person in early recovery. The unique combination of a
personalized and targeted self-regulation toolkit and community and professional support is a key differentiator
for this service.
In phase I of the project, we will develop and pilot test a proof-of-concept RecoVRi VR-mindfulness protocol and
intervention to ascertain feasibility and acceptability (Aim 1). In phase II of the project, a production-quality
intervention will be developed with new VR content created by the TRIPP development team specifically
targeting themes supporting recovery from alcohol, stimulant and opioid SUD separately (Aim 2). We will then
test post-treatment recovery support engagement in the RecoVRi intervention in comparison to treatment as
usual in a randomized comparison trial involving 80 patients receiving inpatient treatment and transitioning to
the home setting (Aim 3). Over the span of both phases, we will seek regulatory guidance from the FDA in order
to attain clearance for use of the RecoVRi intervention as a therapeutic medical device (Aim 4).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金